Literature DB >> 21216971

Differentiation-dependent differences in murine T cell susceptibility to negative regulation by the lung.

Rhea Y Busick1, Rama D Yammani, Martha A Alexander-Miller.   

Abstract

A large number of viral infections are contracted via the respiratory route. Thus, an effective immune response at this site is of vital importance. Past studies in murine models analyzing a number of viruses have reported that CD8(+) effector T cells entering the lung after respiratory infection exhibit significant functional inactivation. The impaired function in these cells has been proposed to be the result of infection-induced changes in the lung; however, we have found that loss of function can occur in effector CD8(+) T cells present in the lung, even in the absence of infection. This functional inactivation takes place within 48 hours of entry into the lung, and is seen only in effector cells residing in the lung parenchyma, and not the airway. In this study, we have extended our findings to show that functional impairment of these effector cells is not initiated by bone marrow-derived cells, and is independent of proliferation in the lung tissue. Of critical importance, we have also determined that the susceptibility to functional inactivation is a common property shared by most effector cells. Finally, we show that the susceptibility to loss of function is actively regulated throughout differentiation. Although naive CD8(+) T cells, like effector cells, are negatively regulated as a result of residence in the lung, memory cells exhibit profound resistance to functional inactivation. The selective resistance of CD8(+) memory cells may allow the host to limit damage during the effector phase while retaining a protective response that can effectively limit subsequent infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216971      PMCID: PMC3095980          DOI: 10.1165/rcmb.2010-0377OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  32 in total

1.  High avidity CD8+ T cells are the initial population elicited following viral infection of the respiratory tract.

Authors:  Peter M Gray; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

2.  The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection.

Authors:  Steven J Ray; Suzanne N Franki; Robert H Pierce; Snezhana Dimitrova; Victor Koteliansky; Andrew G Sprague; Peter C Doherty; Antonin R de Fougerolles; David J Topham
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

3.  The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production.

Authors:  M D Puente Navazo; D Valmori; C Rüegg
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

4.  Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

Authors:  L Gorelik; R A Flavell
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  A novel role of metalloproteinase in cancer-mediated immunosuppression.

Authors:  B C Sheu; S M Hsu; H N Ho; H C Lien; S C Huang; R H Lin
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

7.  Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology.

Authors:  T Hussell; A Pennycook; P J Openshaw
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

8.  Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells.

Authors:  Lumei Xu; Heesik Yoon; Min Q Zhao; Jun Liu; Chilakamarti V Ramana; Richard I Enelow
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

9.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Authors:  Norihiko Watanabe; Maya Gavrieli; John R Sedy; Jianfei Yang; Francesca Fallarino; Susan K Loftin; Michelle A Hurchla; Natalie Zimmerman; Julia Sim; Xingxing Zang; Theresa L Murphy; John H Russell; James P Allison; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

Review 10.  LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination.

Authors:  Frédéric Triebel
Journal:  Trends Immunol       Date:  2003-12       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.